Atricure Inc. buy JPMorgan Chase & Co.
Start price
16.12.25
/
50%
€34.60
Target price
16.12.26
€40.85
Performance (%)
-31.21%
Price
02.04.26
€23.80
Summary
This prediction is currently active. Massive losses of -31.21% have been the result for the BUY prediction by JPMorgan_Chase___Co_. This prediction currently runs until 16.12.26. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Atricure Inc. | -4.032% | -4.032% |
| iShares Core DAX® | 2,49 % | -5,94 % |
| iShares Nasdaq 100 | 1,65 % | -2,46 % |
| iShares Nikkei 225® | 0,55 % | -7,60 % |
| iShares S&P 500 | 1,35 % | -2,94 % |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Atricure Inc. diskutieren
AtriCure (NASDAQ:ATRC) had its price target raised by analysts at JPMorgan Chase & Co. from $42.00 to $48.00. They now have an "overweight" rating on the stock.
Ratings data for ATRC provided by MarketBeat